stockrow
Friday 6 November 2026
Export HDSN’s income statement to Excel — free account
Hudson Technologies, Inc.
HDSN Basic Materials Specialty Chemicals
Hudson Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $246.6 million, up 4.00% from fiscal 2024.
- Revenue
- −19.7%
- EPS
- −82.1%
- Free cash flow
- +43.4%
Quarter to September 2026, against a year earlier
4.19
0.10
+2.44%
Follow HDSN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
18.51 | 18.50 | 27.62 | 0.00 |
P/S ratio |
1.21 | 0.99 | 0.94 | 0.89 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(9.17) | (19.43) | 35.26 | 21.36 | |
P/B ratio |
1.23 | 1.05 | 0.99 | 0.88 | |
Price to Tangible BV |
1.79 | 1.54 | 1.43 | 1.26 | |
EV/Sales |
1.17 | 1.03 | 0.96 | 0.87 | |
EV/EBITDA |
11.67 | 11.13 | 13.54 | 11.64 | |
EV/Operating CF |
(91.46) | (8.62) | (8.29) | (7.46) | |
EV/FCF |
(35.11) | (7.45) | (7.12) | (6.69) | |
Quick Ratio |
0.97 | 0.97 | 1.12 | 1.10 | |
Current Ratio |
3.26 | 3.38 | 3.23 | 3.40 | |
Net Debt/EBITDA |
4.05 | (5.94) | (2.79) | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.79 | 0.82 | 0.80 | 0.74 | |
Operating CF/Net income |
3.77 | (38.80) | 1.38 | 4.98 | |
Capex/Depreciation |
(0.75) | (0.60) | (0.32) | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
31.35% | 15.84% | 15.87% | 18.19% | |
Intangible Assets out of Total Assets |
0.24 | 0.25 | 0.23 | 0.23 | |
Share Based Compensation of Revenue |
1.06% | 0.28% | 0.86% | 0.39% | |
Graham Net Nets |
0.45 | 0.53 | 0.58 | 0.66 | |
Graham Number |
6.82 | 6.34 | 5.20 | 0.00 | |
Earnings Yield |
5.40% | 5.40% | 3.62% | (0.43%) | |
Free Cash Flow Yield |
(2.76%) | (14.01%) | (14.30%) | (14.58%) | |
Revenue per Share |
1.02 | 1.42 | 1.86 | 1.41 | |
Operating CF per Share |
(0.75) | (0.30) | 0.16 | 0.24 | |
Capex per Share |
(0.03) | (0.03) | (0.01) | (0.01) | |
Free Cash Flow per Share |
(0.77) | (0.33) | 0.15 | 0.23 | |
Cash per Share |
0.91 | 0.46 | 0.61 | 0.84 | |
Shareholders Equity per Share |
5.58 | 5.62 | 5.78 | 5.83 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
5.58 | 5.62 | 5.78 | 5.83 | |
Free Cash Flow |
(33.65) | (13.88) | 6.27 | 9.67 | |
Working Capital |
146.24 | 142.96 | 150.65 | 153.65 | |
Capital Expenditures |
(1.11) | (1.07) | (0.58) | (0.47) | |
Net Current Asset Value |
135.58 | 131.84 | 139.35 | 143.38 | |
EV/EBIT |
15.58 | 15.32 | 21.16 | 233.79 | |
Capex to Sales |
0.03 | 0.02 | 0.01 | 0.01 | |
Price to Operating Income |
16.09 | 14.68 | 20.78 | 239.51 | |
| Other line items | |||||
Average Receivables |
21.46 | 36.17 | 44.60 | 32.51 | |
Average Payables |
14.90 | 14.43 | 17.79 | — | |
Average Inventory |
116.09 | 104.52 | 102.90 | 114.46 | |
Average Assets |
310.65 | 308.40 | 319.96 | 329.44 | |
Average Common Equity |
244.62 | 242.25 | 249.02 | 255.71 |
Columns are period end dates · fundamentals updated 5 Nov 2026